0:00
15:30
Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention). NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.
Weitere Episoden von „Primary Care Pod“
Verpasse keine Episode von “Primary Care Pod” und abonniere ihn in der kostenlosen GetPodcast App.